Keyphrases
Antibody Response
100%
Rat Model
100%
Recombinant Human
100%
Hemophilia
80%
Neutralizing Antibodies
60%
Factor VIII (FVIII)
40%
Intravenous Administration
20%
Inhibitor Response
20%
Genotype
20%
Time Response
20%
Binding Antibodies
20%
Immune Response
20%
Adjuvant Effect
20%
Spontaneous Bleeding
20%
Human Patients
20%
Treatment Complications
20%
Blood Samples
20%
Dosing Regimen
20%
Intravenous Injection
20%
No Significant Difference
20%
Intervention Studies
20%
Twice Daily
20%
Bleeding
20%
Immunological Characterization
20%
Pharmacology, Toxicology and Pharmaceutical Science
Haemophilia A
100%
Recombinant Blood Clotting Factor 8
100%
Rat Model
100%
Neutralizing Antibody
50%
Ciclonicate
33%
Replacement Therapy
16%
Intervention Study
16%
Immunology and Microbiology
Treatment Response Time
20%